Raloxifene Reduces Incidence of Breast Cancer by 58-66% and May Reduce Risk of Endometrial Cancer in Postmenopausal Women

University of Pennsylvania Cancer Center
Ultima Vez Modificado: 18 de mayo del 1998

Translation for this article does not exist